Blood Res.  2020 Jun;55(2):117-120. 10.5045/br.2020.2020047.

Response of multifocal acquired demyelinating sensorimotor neuropathy associated with atypical chronic lymphocytic leukemia to rituximab therapy

• Jain A
• Prasad P
• Chaudhry S
• Gupta DK
• Saluja S

• KMID: 2503488
• DOI: http://doi.org/10.5045/br.2020.2020047

Figure

• 

  Fig. 1 Flow cytometry plots showing gated clonal B-cells (A) dual positivity for CD19 and CD20, (B) dual negativity for CD5 and CD23, (C) positivity for CD200, and (D) negativity for CD123, consistent with B-CLPD (atypical CLL).

Reference

1. Rison RA, Beydoun SR. 2016; Paraproteinemic neuropathy: a practical review. BMC Neurol. 16:13. DOI: 10.1186/s12883-016-0532-4. PMID: 26821540. PMCID: PMC4731930.

2. Kelly JJ Jr, Kyle RA, O'Brien PC, Dyck PJ. 1981; Prevalence of monoclonal protein in peripheral neuropathy. Neurology. 31:1480–3. DOI: 10.1212/WNL.31.11.1480. PMID: 6273767.

3. Jain A, Haynes R, Kothari J, Khera A, Soares M, Ramasamy K. 2019; Pathophysiology and management of monoclonal gammopathy of renal significance. Blood Adv. 3:2409–23. DOI: 10.1182/bloodadvances.2019031914. PMID: 31409583. PMCID: PMC6693003.

4. Fermand JP, Bridoux F, Dispenzieri A, et al. 2018; Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood. 132:1478–85. DOI: 10.1182/blood-2018-04-839480. PMID: 30012636.

5. Nobile-Orazio E, Bianco M, Nozza A. 2017; Advances in the treatment of paraproteinemic neuropathy. Curr Treat Options Neurol. 19:43. DOI: 10.1007/s11940-017-0479-9. PMID: 29034435.

6. Dimachkie MM, Barohn RJ, Katz J. 2013; Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants. Neurol Clin. 31:533–55. DOI: 10.1016/j.ncl.2013.01.001. PMID: 23642723. PMCID: PMC4098937.

7. Sandes AF, de Lourdes Chauffaille M, Oliveira CR, et al. 2014; CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry. Cytometry B Clin Cytom. 86:98–105. DOI: 10.1002/cytob.21128.

8. Swerdlow SH, Campo E, Harris NL, editors. 2017. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. IARC Press;Lyon, France:

9. Wang HY, Zu Y. 2017; Diagnostic algorithm of common mature B-cell lymphomas by immunohistochemistry. Arch Pathol Lab Med. 141:1236–46. DOI: 10.5858/arpa.2016-0521-RA. PMID: 28608720.

10. Singh G. 2016; Serum free light chain assay and k/l ratio performance in patients without monoclonal gammopathies: high false-positive rate. Am J Clin Pathol. 146:207–14. DOI: 10.1093/ajcp/aqw099. PMID: 27473738.

11. Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR. 2001; Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood. 97:2900–2. DOI: 10.1182/blood.V97.9.2900. PMID: 11313287.

12. Stübgen JP. 2015; Autoantibody-mediated sensory polyneuropathy associated with indolent B-cell non-Hodgkin's lymphoma: a report of two cases. J Clin Neurol. 11:283–6. DOI: 10.3988/jcn.2015.11.3.283. PMID: 25749823. PMCID: PMC4507385.

13. Chen LY, Keddie S, Lunn MP, et al. 2020; IgM paraprotein-associated peripheral neuropathy: small CD20-positive B-cell clones may predict a monoclonal gammopathy of neurological significance and rituximab responsiveness. Br J Haematol. 188:511–5. DOI: 10.1111/bjh.16210. PMID: 31588566.

14. Briani C, Visentin A, Salvalaggio A, et al. 2017; Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients. Haematologica. 102:e140–3. DOI: 10.3324/haematol.2016.153064. PMID: 27927770. PMCID: PMC5395126.